AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
70.22
+1.49 (2.17%)
At close: Apr 14, 2026, 4:00 PM EDT
75.99
+5.77 (8.22%)
After-hours: Apr 14, 2026, 7:49 PM EDT

AnaptysBio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,0191,358403570884961
Market Cap Growth
252.98%236.68%-29.18%-35.53%-8.03%63.35%
Enterprise Value
1,9941,05932.2194.84460.19432.09
Last Close Price
70.2248.4813.2421.4230.9934.75
PE Ratio
--105.39-2.59-3.52-6.78-16.47
Forward PE
-----16.86
PS Ratio
8.595.794.4233.2185.9015.21
PB Ratio
51.7536.515.696.473.372.70
P/TBV Ratio
56.5337.475.306.553.332.67
P/FCF Ratio
102.7469.27-2.97-4.68-11.95-20.32
P/OCF Ratio
102.2868.96-2.98-4.72-12.01-20.92
EV/Sales Ratio
8.504.510.3511.3644.746.84
EV/EBITDA Ratio
41.1421.85-0.28-1.19-4.02-7.69
EV/EBIT Ratio
41.6322.11-0.28-1.19-4.00-7.61
EV/FCF Ratio
101.6753.99-0.24-1.60-6.22-9.14
Debt / Equity Ratio
0.320.320.200.180.070.05
Debt / EBITDA Ratio
0.290.29-0.14-0.11-0.17-0.37
Debt / FCF Ratio
0.720.72-0.12-0.15-0.26-0.44
Net Debt / Equity Ratio
-8.00-8.00-5.21-4.24-1.61-1.48
Net Debt / EBITDA Ratio
-6.14-6.143.232.283.689.38
Net Debt / FCF Ratio
-15.17-15.172.723.075.7011.15
Asset Turnover
0.550.550.190.030.020.12
Quick Ratio
8.948.949.3810.6216.9934.10
Current Ratio
9.079.079.5110.8717.1634.40
Return on Equity (ROE)
-24.49%-24.49%-182.71%-93.44%-41.62%-15.35%
Return on Assets (ROA)
11.15%11.15%-24.56%-30.94%-18.37%-10.72%
Return on Invested Capital (ROIC)
132.91%132.91%-284.60%-192.81%-102.29%-135.60%
Return on Capital Employed (ROCE)
12.54%12.54%-26.94%-32.91%-19.01%-11.10%
Earnings Yield
-0.66%-0.95%-38.67%-28.38%-14.75%-6.07%
FCF Yield
0.97%1.44%-33.63%-21.35%-8.37%-4.92%
Buyback Yield / Dilution
-1.32%-1.32%-5.42%4.41%-2.68%-0.47%
Total Shareholder Return
-1.32%-1.32%-5.42%4.41%-2.68%-0.47%
Updated Mar 3, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q